Evaluating Autoencoders for Dimensionality Reduction of MRI-derived Radiomics and Classification of Malignant Brain Tumors

Sci Stat Database Manag. 2023 Jul:2023:1. doi: 10.1145/3603719.3603737. Epub 2023 Aug 27.

Abstract

Malignant brain tumors including parenchymal metastatic (MET) lesions, glioblastomas (GBM), and lymphomas (LYM) account for 29.7% of brain cancers. However, the characterization of these tumors from MRI imaging is difficult due to the similarity of their radiologically observed image features. Radiomics is the extraction of quantitative imaging features to characterize tumor intensity, shape, and texture. Applying machine learning over radiomic features could aid diagnostics by improving the classification of these common brain tumors. However, since the number of radiomic features is typically larger than the number of patients in the study, dimensionality reduction is needed to balance feature dimensionality and model complexity. Autoencoders are a form of unsupervised representation learning that can be used for dimensionality reduction. It is similar to PCA but uses a more complex and non-linear model to learn a compact latent space. In this work, we examine the effectiveness of autoencoders for dimensionality reduction on the radiomic feature space of multiparametric MRI images and the classification of malignant brain tumors: GBM, LYM, and MET. We further aim to address the class imbalances imposed by the rarity of lymphomas by examining different approaches to increase overall predictive performance through multiclass decomposition strategies.

Keywords: autoencoders; dimensionality reduction; malignant brain tumors; radiomics.